Summary & Overview
CPT 67415: Orbital Needle Biopsy for Diagnostic Evaluation
CPT code 67415 represents a percutaneous needle biopsy of the orbit used to obtain tissue from suspicious lesions in the bony cavity that contains the eye. As a focused diagnostic procedure, orbital needle biopsy provides tissue for histopathologic and microbiologic evaluation and can be critical to distinguishing benign from malignant or infectious processes that affect vision and ocular structures. Nationally, this code is relevant to ophthalmology, oculoplastics, and head and neck surgical practices, as well as facilities that perform outpatient surgical diagnostics.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on clinical use, typical sites of service, common billing modifiers, and the policy and reimbursement landscape as it relates to orbital diagnostic procedures. The publication highlights procedural intent, common clinical indications, coding nuances for outpatient settings, and areas where payers commonly apply medical necessity review.
This summary equips clinicians, coding professionals, and policy stakeholders with an understanding of CPT code 67415’s clinical role, expected settings of care, and the payer mix likely to process claims for this service. Data not available in the input is noted where specific benchmarks, ICD-10 linkage, and provider taxonomies would normally appear.
Billing Code Overview
CPT code 67415 describes a needle biopsy of the orbit, a minimally invasive procedure in which a provider uses a narrow needle to extract material from an area of suspicious tissue within the bony orbit that houses the eye. The collected specimen is sent to a laboratory for pathologic analysis to determine the nature of the suspicious tissue.
Service type: Diagnostic procedure — percutaneous orbital biopsy
Typical site of service: Outpatient surgical suite, ambulatory surgery center, or hospital outpatient department
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient presents to an ophthalmology clinic with progressive proptosis, diplopia, and a palpable orbital mass noted on examination. Orbital imaging (CT or MRI) identifies a focal lesion within the orbit suspicious for neoplasm or inflammatory pseudotumor. After informed consent, an oculoplastic surgeon performs a fine-needle aspiration biopsy of the orbital lesion to obtain cytologic material for pathologic analysis. The procedure is performed in an outpatient ophthalmology procedure room under local anesthesia with monitored sedation as needed. The sample is submitted to the pathology laboratory for cytology and possible ancillary testing (immunohistochemistry or flow cytometry) to establish a definitive diagnosis and guide further management (surgical excision, radiation, or systemic therapy). Typical workflow includes pre-procedure imaging review, coagulation assessment if indicated, sterile field preparation, ultrasound or CT guidance if required, needle aspiration, specimen handling and labeling, and postoperative observation for bleeding, vision changes, or globe injury before discharge to home with instructions to return for results and follow-up care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the physician's interpretation or procedural service component is billed separately from technical services (rare for biopsy but applicable if separate pathology billing occurs). |